Cyclooxygenase Inhibitors Induce Colon Cancer Cell Apoptosis Via PPAR 14-3-3 Pathway
Non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 (COX-2) inhibitors (COXIBs) induce cancer cell apoptosis via several signaling pathways. There is evidence that they induce colon cancer cell apoptosis by suppressing peroxisome proliferator-activated receptor δ (PPARδ) through inhibition of COX-2-derived prostacyclin (PGI2). PGI2 activates PPARδ resulting in binding of PPARδ to specific PPAR response elements (PPRE) of target genes. We have identified 14-3-3ε as one of the genes that are upregulated by PPARδ. Elevated 14-3-3ε proteins in cytosol enhance sequestration of Bad and reduce mitochondrial damage by Bad and thereby control apoptosis. NSAIDs and COXIBs block PGI2 production, thereby reducing PPARδ DNA binding activity and abrogating 14-3-3e upregulation. Furthermore, the COX-2 inhibitors suppress PPARδ expression. Suppression of PPARδ leads to reduced 14-3-3e and hence a decline in Bad sequestration, resulting in an increased Bad-induced apoptosis via the mitochondrial death pathway.
- Application of Phage Display to Discovery of Tumor-Specific Homing Peptides: Developing Strategies for Therapy and Molecular Ima
- Use of Antisense Oligonucleotides for Therapy: Manipulation of Apoptosis Inhibitors for Destruction of Lung Cancer Cells
- Homogeneous, Bioluminescent Proteasome Assays
- In Vivo Particle-Mediated Gene Transfer for Cancer Therapy
- Analysis of Growth Properties and Cell Cycle Regulation Using Mouse Embryonic Fibroblast Cells
- Cell Separations by Flow Cytometry
- Identification of Protein Interaction Partners by the Yeast Two-Hybrid System
- Molecular Characterization of STAT Signaling in Inflammation and Tumorigenesis
- Purification of the Mitotic Checkpoint Complex, an Inhibitor of the APC/C From HeLa Cells
- 报告基因检测技术